Basic information Safety Supplier Related

BI-3406

Basic information Safety Supplier Related

BI-3406 Basic information

Product Name:
BI-3406
Synonyms:
  • BI-3406
  • SOS1-IN-2
  • N-((R)-1-(3-Amino-5-(trifluoromethyl)phenyl)ethyl)-7-methoxy-2-methyl-6-(((S)-tetrahydrofuran-3-yl)oxy)quinazolin-4-amine
  • 4-Quinazolinamine, N-[(1R)-1-[3-amino-5-(trifluoromethyl)phenyl]ethyl]-7-methoxy-2-methyl-6-[[(3S)-tetrahydro-3-furanyl]oxy]-
  • N-[(1R)-1-[3-Amino-5-(trifluoromethyl)phenyl]ethyl]-7-methoxy-2-methyl-6-[(3S)-oxolan-3-yl]oxyquinazolin-4-amine
  • N-[(1R)-1-[3-Amino-5-
  • KRAS,interaction,anticancer,Inhibitor,BI3406,BI 3406,inhibit,Son,Sevenless,GTP-loaded,BI-3406,Ras,p38 MAPK,orally,SOS1
  • N-[(1R)-1-[3-amino-5-(trifluoromethyl)phenyl]ethyl]-7-methoxy-2-methyl-6-[(3S)-tetrahydrofuran-3-yl]oxy-quinazolin-4-amine
CAS:
2230836-55-0
MF:
C23H25F3N4O3
MW:
462.46
Product Categories:
  • APIs
  • API
Mol File:
2230836-55-0.mol
More
Less

BI-3406 Chemical Properties

Boiling point:
534.5±50.0 °C(Predicted)
Density 
1.347±0.06 g/cm3(Predicted)
storage temp. 
Store at -20°C
solubility 
DMSO:100.0(Max Conc. mg/mL);216.23(Max Conc. mM)
Ethanol:100.0(Max Conc. mg/mL);216.23(Max Conc. mM)
form 
A solid
pka
6.58±0.70(Predicted)
color 
White to off-white
InChIKey
XVFDNRYZXDHTHT-PXAZEXFGSA-N
SMILES
N1=C2C(C=C(O[C@H]3CCOC3)C(OC)=C2)=C(N[C@@H](C2=CC(C(F)(F)F)=CC(N)=C2)C)N=C1C
More
Less

BI-3406 Usage And Synthesis

Uses

BI-3406 (compound I-6) is an orally active, highly potent and selective inhibitor of the interaction between KRAS and Son of Sevenless 1 (SOS1) with an IC50 of 6 nM. BI-3406 potently reduces the formation of GTP-loaded KRAS, and inhibits MAPK pathway signaling. BI-3406 has anticancer activity[1][2].

IC 50

KRAS-SOS1: 6 nM (IC50)

References

[1] Michael Gmachl, et al. Novel benzylamino substituted quinazolines and derivatives as sos1 inhibitors. WO2018115380A1.
[2] Marco H Hofmann, et al. Abstract PL06-01: Discovery of BI-3406: A potent and selective SOS1::KRAS inhibitor opens a new approach for treating KRAS-driven tumors. December 2019.

BI-3406Supplier

ShangHai Caerulum Pharma Discovery Co., Ltd. Gold
Tel
18149758185
Email
sales-cpd@caerulumpharma.com
Anqing YanZhi Pharma Discovery Co.,Ltd. Gold
Tel
18055651951
Email
2272561977@qq.com
Shanghai Topbiochem Technology Co., Ltd
Tel
021-58170097
Email
info@topbiochem.com
Guangzhou Isun Pharmaceutical Co., Ltd
Tel
020-39119399 18927568969
Email
isunpharm@qq.com
Nanjing Sunlida Biological Technology Co., Ltd.
Tel
025-57798810
Email
sales@sunlidabio.com